CME Group Inc. (NASDAQ:CME) Shares Bought by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 77.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,298 shares of the financial services provider’s stock after acquiring an additional 568 shares during the period. Catalyst Capital Advisors LLC’s holdings in CME Group were worth $286,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CME. Y.D. More Investments Ltd purchased a new stake in CME Group during the second quarter valued at about $36,000. Thurston Springer Miller Herd & Titak Inc. increased its position in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. increased its position in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC raised its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after buying an additional 170 shares during the period. Finally, New Covenant Trust Company N.A. acquired a new position in CME Group during the first quarter valued at approximately $82,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CME shares. Citigroup increased their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. JPMorgan Chase & Co. raised their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Morgan Stanley boosted their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Piper Sandler increased their target price on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, Bank of America raised their target price on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $222.73.

CME Group Trading Up 0.9 %

NASDAQ CME opened at $225.19 on Wednesday. The company has a market capitalization of $81.09 billion, a price-to-earnings ratio of 23.68, a price-to-earnings-growth ratio of 5.62 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company’s fifty day moving average price is $221.24 and its two-hundred day moving average price is $209.67.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.25 earnings per share. As a group, research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is currently 48.37%.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.